Search

everythinglearnresearchcommunity

for

Search:↓

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Nanoparticles show promise for better wound healing, but more research is needed to ensure safety and effectiveness.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

NH-Tween-80 is a promising stable gel for treating acne.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Dissolving microneedle patches can effectively deliver drugs over time.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

TheDES improve drug delivery through the skin but need more safety checks.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Finasteride may cause side effects; more research needed.